Outset Medical
PublicOutset Medical is now publicly traded
The data on this page reflects Outset Medical's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Sep 14, 2020
Last Round
Private Placement
Jan 6, 2025
Total Funding Raised
$835.1M
Company Overview
Outset Medical is a medical technology company that offers the Tablo machine, which simplifies and lowers the cost of dialysis while providing Renal Replacement Therapy in hospitals, chronic care in dialysis clinics, and home dialysis options.
Sector
Medical Technology
AI Layer
Non-AI
Keywords
Outset Medical Comparables
Compare Outset Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediBeacon | 57% | |
| Alio | 56% | |
| Théradial | 54% |
Outset Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jan 6, 2025 | ||||
| IPO | Sep 14, 2020 | ||||
| Series E | Feb 4, 2020 | ||||
| Series D | Aug 28, 2018 | ||||
| Series C | May 3, 2017 | ||||
Series B | Jun 9, 2015 |
Outset Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Vertical Group | Series C, Series B |
| Perceptive Advisors | Series E, Series D, Series C, Series B, Private Placement |
| Baxter Ventures | Series D |
| Fidelity Management & Research Company | Series E, Series D, Series C, Series B |
| BofA Securities | IPO |
| Morgan Stanley | IPO |
| T. Rowe Price | Series E, Series D, Series C |
Outset Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access